Citigroup Inc Zynex Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Zynex Inc stock. As of the latest transaction made, Citigroup Inc holds 31,122 shares of ZYXI stock, worth $243,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,122

Previous 4,800 548.38%

Holding current value

$243,062

Previous $44,000 475.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.19 - $10.31 $189,255 - $271,379	26,322 Added 548.38%	31,122 $253,000
Q2 2024 Aug 12, 2024	BUY	$8.63 - $12.56 $13,833 - $20,133	1,603 Added 50.14%	4,800 $44,000
Q1 2024 May 10, 2024	BUY	$9.86 - $13.74 $4,042 - $5,633	410 Added 14.71%	3,197 $39,000
Q4 2023 Feb 09, 2024	BUY	$7.1 - $10.89 $18,474 - $28,335	2,602 Added 1406.49%	2,787 $30,000
Q3 2023 Nov 09, 2023	SELL	$6.95 - $9.89 $136,379 - $194,071	-19,623 Reduced 99.07%	185 $1,000
Q2 2023 Aug 10, 2023	BUY	$8.59 - $14.56 $57,553 - $97,552	6,700 Added 51.11%	19,808 $189,000
Q1 2023 May 11, 2023	BUY	$9.53 - $16.8 $6,175 - $10,886	648 Added 5.2%	13,108 $157,000
Q4 2022 Feb 09, 2023	BUY	$8.71 - $14.28 $21,304 - $34,928	2,446 Added 24.43%	12,460 $173,000
Q3 2022 Nov 10, 2022	BUY	$7.19 - $9.91 $5,816 - $8,017	809 Added 8.79%	10,014 $91,000
Q2 2022 Aug 10, 2022	SELL	$5.78 - $8.87 $59,574 - $91,423	-10,307 Reduced 52.82%	9,205 $73,000
Q1 2022 May 12, 2022	BUY	$5.14 - $9.35 $20,981 - $38,166	4,082 Added 26.45%	19,512 $122,000
Q4 2021 Feb 10, 2022	BUY	$8.71 - $13.77 $39,430 - $62,336	4,527 Added 41.52%	15,430 $154,000
Q3 2021 Nov 10, 2021	BUY	$10.35 - $15.65 $112,846 - $170,631	10,903 New	10,903 $124,000

Others Institutions Holding ZYXI

# of Institutions

103

Shares Held

8.4M

Call Options Held

200

Put Options Held

1.5K

View Full List

About ZYNEX INC

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $293M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

More about ZYXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account